Skip to contentDavis Aaron I. — iTeos Therapeutics, Inc. insider: 99 transactions · InsiderLensDavis Aaron I.
- See remarks at iTeos Therapeutics, Inc. · on record since Aug 25, 2023
- See remarks at Mirati Therapeutics, Inc. · on record since Aug 15, 2023
- See Remarks at Tyra Biosciences, Inc. · on record since Feb 8, 2024
- See remarks at Tango Therapeutics, Inc. · on record since Aug 15, 2023
- Director at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 27, 2021
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 27, 2021
- 10% owner at ARADIGM CORP · on record since May 30, 2013
- 10% owner at Mirati Therapeutics, Inc. · on record since Jan 15, 2016
- Director at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
- 10% owner at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
- Director at Mirati Therapeutics, Inc. · on record since Dec 10, 2018
- Director at iTeos Therapeutics, Inc. · on record since Jul 30, 2020
- 10% owner at iTeos Therapeutics, Inc. · on record since Jul 30, 2020
- Former 10% Owner at PMV Pharmaceuticals, Inc. · on record since Sep 29, 2020
- 10% owner at PMV Pharmaceuticals, Inc. · on record since Sep 24, 2020
- 10% owner at Pandion Therapeutics, Inc. · on record since Jul 21, 2020
- Director at Tango Therapeutics, Inc. · on record since Sep 3, 2020
- Chief Executive Officer at Tango Therapeutics, Inc. · on record since Sep 3, 2020
- 10% owner at Tyra Biosciences, Inc. · on record since Sep 17, 2021
- 10% owner at Tango Therapeutics, Inc. · on record since Oct 13, 2022
Insider trading activity of Davis Aaron I.
- Transactions on record
- 99
- since Dec 8, 2017
- Open-market buys
- 29
- $110.4M
- Open-market sells
- 26
- $38.3M
- Companies traded
- 6
- last filing Sep 5, 2024
Figures computed from official regulatory filings — methodology.
Companies where Davis Aaron I. has traded
- Tango Therapeutics, Inc.8 tx · $23.2M · Sep 5, 2024
- iTeos Therapeutics, Inc.31 tx · $78.6M · Jun 13, 2024
- Rain Enhancement Technologies Holdco, Inc.14 tx · $27.8M · Jan 26, 2024
- Mirati Therapeutics, Inc.22 tx · $2.8M · Jan 23, 2024
- Tyra Biosciences, Inc.2 tx · $3.5M · Feb 13, 2023
- Odonate Therapeutics, Inc.22 tx · $50M · Nov 19, 2021
Track record of Davis Aaron I.
Statistical track record
Free- Open-market buys
- 30
- Last buy
- Oct 16, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Davis Aaron I.
Co-insiders of Davis Aaron I.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Shah Rajeev M.iTeos Therapeutics, Inc. +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Sep 5, 2024 | OtherD | 65,000 | 0.00 USD | $0 | SEC |
| Jun 13, 2024 | AwardD | 24,200 | 0.00 USD | $0 | SEC |
| May 14, 2024 | Award | 1,142,857 | 17.50 USD | $20M | SEC |
| Jan 26, 2024 | OtherD | -20,000 | — | — | SEC |
| Jan 26, 2024 | OtherD | -35,000 | — | — | SEC |
| Jan 26, 2024 | Other | -79,726 | — | — | SEC |
| Jan 23, 2024 | Other | -43,073 | — | — | SEC |
| Jan 23, 2024 | OtherD | -7,520 | — | — | SEC |
| Jan 23, 2024 | OtherD | -11,000 | — | — | SEC |
| Jan 23, 2024 | Other | -6,808 | — | — | SEC |
| Jan 23, 2024 | OtherD | -25,000 | — | — | SEC |
| Jan 23, 2024 | Other | -4,444 | — | — | SEC |
| Jan 3, 2024 | Award | 6,808 | 58.75 USD | $400K | SEC |
| Oct 17, 2023 | Buy | 500,000 | 6.84 USD | $3.4M | SEC |
| Oct 17, 2023 | Buy | 750,000 | 7.07 USD | $5.3M | SEC |
| Oct 11, 2023 | Award | 475,000 | 5.15 USD | $2.4M | SEC |
| Oct 11, 2023 | AwardD | 2,340,579 | 5.15 USD | $12.1M | SEC |
| Aug 25, 2023 | Sell | -95,516 | 15.63 USD | $1.5M | SEC |
| Aug 25, 2023 | Sell | -219,638 | 16.87 USD | $3.7M | SEC |
| Aug 25, 2023 | Sell | -34,846 | 14.19 USD | $494.5K | SEC |
| Aug 11, 2023 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Jun 15, 2023 | AwardD | 22,383 | 0.00 USD | $0 | SEC |
| Jun 8, 2023 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 8, 2023 | Award | 5,000 | 0.00 USD | $0 | SEC |
| Feb 13, 2023 | Sell | -65,568 | 13.40 USD | $878.6K | SEC |